leflunomid "egis" 15 mg filmovertrukne tabletter
egis pharmaceuticals plc - leflunomid - filmovertrukne tabletter - 15 mg
leflunomid "egis" 20 mg filmovertrukne tabletter
egis pharmaceuticals plc - leflunomid - filmovertrukne tabletter - 20 mg
leflunomid "pharmathen" 10 mg filmovertrukne tabletter
pharmathen s.a. - leflunomid - filmovertrukne tabletter - 10 mg
leflunomid "pharmathen" 15 mg filmovertrukne tabletter
pharmathen s.a. - leflunomid - filmovertrukne tabletter - 15 mg
leflunomid "pharmathen" 20 mg filmovertrukne tabletter
pharmathen s.a. - leflunomid - filmovertrukne tabletter - 20 mg
leflunomid "aurobindo" 15 mg filmovertrukne tabletter
aurobindo pharma (malta) limited - leflunomid - filmovertrukne tabletter - 15 mg
leflunomid "aurobindo" 20 mg filmovertrukne tabletter
aurobindo pharma (malta) limited - leflunomid - filmovertrukne tabletter - 20 mg
leflunomid "egis" 10 mg filmovertrukne tabletter
egis pharmaceuticals plc - leflunomid - filmovertrukne tabletter - 10 mg
teriflunomide "sandoz" 14 mg filmovertrukne tabletter
sandoz a/s - teriflunomid - filmovertrukne tabletter - 14 mg
aubagio
sanofi winthrop industrie - teriflunomide - multipel sclerose - selektive immunosuppressiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).